tiprankstipranks
Trending News
More News >

Gaurav Shah Insider Profile

18 Followers
Gaurav Shah, CEO, Director at Rocket Pharmaceuticals, holds 1.19M shares in Rocket Pharmaceuticals (Ticker: RCKT), holds ― shares in Tourmaline Bio (Ticker: TRML). Most recently, Gaurav Shah Sold ― shares of Rocket Pharmaceuticals on May 22, 2025 for an estimated value of 14.51K.
tipranks
Gaurav Shah

Gaurav Shah
Rocket Pharmaceuticals (RCKT)
CEO, Director

Ranked #6,292 out of 102,674 Corporate Insiders

Profitable Transactions

73%
8 out of 11 Profitable Transactions

Average Return

+25.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
0.00%
A breakdown of Gaurav Shah's holdings

Insider Roles

Rocket Pharmaceuticals
(RCKT)
CEO, Director
Tourmaline Bio
(TRML)
Director
Roles that Gaurav Shah holds in companies

Most Profitable Insider Trade

Stock:
Rocket Pharmaceuticals
(RCKT)
Rating:Informative Sell
Date:Aug 20, 2024 - Today
Return:+69.40%
The most profitable trade made by Gaurav Shah

Gaurav Shah's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Rocket Pharmaceuticals
May 22, 2025
CEO, Director
Informative Sell
14.51K
$3.75M
Tourmaline Bio
Director
List of latest transactions for each holding click on a transaction to see Gaurav Shah's performance on stock

Gaurav Shah insider profile FAQ

What is the percentage of profitable transactions made by Gaurav Shah?
The percentage of profitable transactions made by Gaurav Shah is 73%.
    What is the average return per transaction made by Gaurav Shah?
    The average return per transaction made by Gaurav Shah is 25.80%.
      What stocks does Gaurav Shah hold?
      Gaurav Shah holds: RCKT, TRML stocks.
        What was Gaurav Shah’s latest transaction?
        Gaurav Shah latest transaction was an Informative Sell of $14.51K.
          What was Gaurav Shah's most profitable transaction?
          Gaurav Shah’s most profitable transaction was an Informative Sell of RCKT stock on August 20, 2024. The return on the trade was 69.40%.
            What is Gaurav Shah's role in Rocket Pharmaceuticals?
            Gaurav Shah's role in Rocket Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.